MASCC

Join global health care professionals to minimize therapy-induced side effects, symptoms & complications associated with cancer. #SuppOnc

[MASCC @CancerCareMASCC]

This video highlights the real impact of CINV and why prevention matters from the start. 

The voiceover is provided by Eva Schumacher-Wulf, who sadly passed away earlier this year. This video honors her tireless work and legacy.

[CA: A Cancer Journal for Clinicians @CACancerJournal]

Many oncology clinics lack gender-affirming practices. @CancerCareMASCC offer guidance on cancer care for transgender & gender-diverse people:

✅ Avoid gender assumptions
✅ Use affirmed names/pronouns
✅ Provide gender-neutral facilities

https://t.co/Q921oNaIDy

@OncoAlert

[touchONCOLOGY @touchONCOLOGY]

How can we support patients with EGFR-mutant early-stage #NSCLC throughout treatment?

Dr. James Yang explores biomarker testing, treatment duration, adverse event management, and shared decision-making in our latest touchEXPERT FOCUS.

▶️ Watch & earn #CME: https://t.co/BBSU3tqG00

[MASCC @CancerCareMASCC]

Join us for an upcoming MASCC Webinar: ADC Toxicities in the Real World: Recognize, Differentiate, Act: A Case-Based Approach to Prevention, Recognition, and Management

Learn more or register here: https://t.co/c3WejtprSV

[Darcy Burbage, DNP, RN, AOCN @DarcyBurbage]

Identifying needs is the first step. Connecting individuals living w/and beyond cancer with appropriate care and resources is where we make a difference!

[touchONCOLOGY @touchONCOLOGY]

🦠 The microbiome in oncology: from emerging evidence to clinical practice

How prepared is the oncology community to translate microbiome science into patient care?

In a new Q&A, Prof Hannah Wardill and Dr Maya Davies explore findings from an international survey conducted through the Multinational Association of Supportive Care in Cancer (@CancerCareMASCC) examining current knowledge, perceptions and practices around the gut microbiome.

They discuss antimicrobial stewardship, probiotics, faecal microbiota transplantation and the practical and safety challenges facing microbiome programmes in oncology.

Read the full Q&A on touchONCOLOGY. 👇
https://t.co/3zAEvrrTm0

#Oncology #CancerResearch #Microbiome #MASCC #PrecisionMedicine

[MASCC @CancerCareMASCC]

MASCC is proud to offer Conference Scholarships,
which provide financial support to oncology healthcare professionals from low-income countries to present at #MASCC26.

Find out more and check your eligibility on our website: https://t.co/Fy4prjP1gt

[MASCC @CancerCareMASCC]

Abstract submissions are now open for #MASCC27!

Abstract submissions which include a Conference Scholarship application are due by December 16, 2026 at 3:00 PM EST.

All other abstracts are due by January 13, 2027 at 3:00 PM EST

Learn more: https://t.co/CEooABs64O

[touchONCOLOGY @touchONCOLOGY]

🎗️ What does the future of supportive cancer care look like?

From AI and real-time toxicity monitoring to exercise, nutrition and behavioural interventions, Prof Joanne Bowen explores the innovations shaping supportive oncology following MASCC/ISOO 2026 in Melbourne.

🔬 Discover key insights on precision supportive care, multidisciplinary collaboration and the importance of making emerging advances accessible and equitable for all.

🔗 Read the full insight: https://t.co/hQj104DslH

@CancerCareMASCC
#MASCC2026 #SupportiveCare #Oncology #CancerCare #CancerResearch

[Ana Cardeña @AnaCardea5]

Excited to share our new scoping review just published in the Journal of Cancer Survivorship! 🎉 Led by the MASCC Disparities Committee:
https://t.co/gZmEJRoU5H
@CancerCareMASCC @alexchan928 @EnriqueSoto8 @DrNicolasHart @CharlesJiangMD
@MerryTea @hernaez_paula

[MASCC @CancerCareMASCC]

Join us for an upcoming MASCC Webinar: Optimizing ILD Management in Oncology: Early Detection, MDT Approaches & Retreatment Considerations

Learn more or register: https://t.co/SRHXK2VnuG

[MASCC @CancerCareMASCC]

Cancer-related cognitive impairment affects many survivors long after treatment ends. In this episode of MASCC's Supportive Care Digest, @Dr_Harutyunyan
gives an overview of Emerging From the Haze, a promising virtual solution.

Original publication: https://t.co/hFNDZwW78z

[touchONCOLOGY @touchONCOLOGY]

How can immunotherapy decisions be individualized for patients with recurrent/metastatic nasopharyngeal carcinoma (R/M NPC)?

Explore the latest evidence, guidelines, and expert insights from Dr. Deborah Wong on selecting immunotherapy-based treatment strategies according tol patient- and disease-specific factors.

🎓 Earn CME credit and update your practice: https://t.co/sMS5yxsb8R

@AHNSinfo @ASCO @oncologyCOA
#Oncology #Immunotherapy #MedEd #CME #HeadAndNeckCancer

[MASCC @CancerCareMASCC]

Now available: “Rebuilding Metabolic Health After Cancer: The Role of a Nutrition Rehabilitation Clinic” from @AtriumHealthWFB Comprehensive Cancer Center Supportive Oncology Grand Rounds video series.

Watch now: https://t.co/ZXzG81cheF

[Darcy Burbage, DNP, RN, AOCN @DarcyBurbage]

Improving adherence to oral therapies requires a proactive, structured approach & strong collaboration between patients and the healthcare team. Here are four ways @oncologynursing can help support adherence.
https://t.co/nBKMscGH4U

[MASCC @CancerCareMASCC]

In our latest Supportive Care Digest, @JordanCurry2 summarizes a recent paper from @AvanciniAlice and colleagues looking at physical activity level and its determinants in patients with cancer.

Original paper: https://t.co/dKiAlrSQ5Q

[MASCC @CancerCareMASCC]

Join us for an upcoming MASCC Webinar: How to Increase Drug Access and Decrease Financial Toxicity

Tuesday, September 22, 2026

The format of the webinar will be a panel discussion

Register: https://t.co/rQjTvziEeH

[touchONCOLOGY @touchONCOLOGY]

🔬 Is your approach to #PDAC evolving with the latest evidence?

Join leading oncology experts as they discuss biomarker-informed treatment decisions, emerging KRAS-targeted therapies, ADCs, and sequencing strategies in this accredited touchPANEL DISCUSSION.

🎓 Watch now and earn CME credits: https://t.co/sfMZavkNOB

@AACR @ASCO @myESMO
#PancreaticCancer #Oncology #PrecisionMedicine

[touchONCOLOGY @touchONCOLOGY]

How should the latest #ASCO2026 data be interpreted alongside other congress findings in HER2-altered #NSCLC?

Join Dr. Julia Rotow, Dr. Misako Nagasaka and Prof. David Planchard as they discuss the latest evidence, clinical implications and future directions.

Watch now: https://t.co/bBu2Hk2fQ7

@JuliaRotow @MNagasaka @dplanchard

[MASCC @CancerCareMASCC]

Our latest Supportive Care Digest from @Dr_Harutyunyan looks at new national data from Czechia revealing a major gap in pediatric cancer rehabilitation.

Original publication from Dr. Filip Jevič and colleagues: https://t.co/vlGORy1c8A